Trial Condition(s):


Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

Bayer Identifier:

14175 Identifier:


EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

The purposes of this study are:
- To evaluate patient satisfaction for efficacy and tolerability of heavy menstrual bleeding treatment by Mirena.
- To collect italian data for Mirena in clinical routine.

Inclusion Criteria
- Women diagnosed with Idiopathic Menorrhagia and Mirena inserted for a period no longer than three months according to the assessment of the investigator and according to the international and national  guidelines. These women should also accept to be on contraception during the time period that they have Mirena in situ
 - Body Mass Index = 18-30
Exclusion Criteria
- One or more of the following disorders: Current or recurrent pelvic inflammatory disease; infection of the lower genital tract; postpartum endometritis; septic abortion during the past three months; cervicitis; cervical dysplasia; uterine or cervical malignancy; undiagnosed abnormal uterine bleeding; congenital or acquired abnormality of the uterus including fibroids if they distort the uterine cavity; conditions associated with increased susceptibility to infections; acute liver disease or liver tumor; known hypersensitivity to any of the constituents of the product
 - Nulliparity
 - Consumption of Iron, Antiprostaglandins, hormonal drugs and any medication  that could effect bleeding  should be stopped at least 3 months before the first visit and should not be used during the course of the study.
 - History of diabetes mellitus, cardiovascular disease and thyroid abnormalities
 - Anticoagulation therapy
 - Cancer history including breast cancer

Trial Summary

Enrollment Goal
Trial Dates
Could I receive a placebo?
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteers

Where to Participate


Investigative Site

Many Locations, Italy

Trial Design